Sanofi (SNY) Earnings Date, Estimates & Call Transcripts $48.39 +0.11 (+0.23%) (As of 08:32 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sanofi Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 6EstimatedActual EPS (Oct. 25) $1.57 Beat By $1.35 Consensus EPS (Oct. 25) $0.22 Sanofi posted Q3 2024 earnings on October 25, 2024, reporting an EPS of $1.57, which topped analysts' consensus estimates of $0.22 by $1.35. Quarterly revenue rose 12.3% year-over-year to $13.44 billion, below analyst estimates of $16.59 billion. With a trailing EPS of $1.96 and a P/E Ratio of 24.66, Sanofi's earnings are expected to grow 12.35% next year, from $4.29 to $4.82 per share. Conference Call TranscriptConference Call AudioSNY Upcoming EarningsSanofi's next earnings date is estimated for Thursday, February 6, 2025, based off prior year's reporting schedules. Get Sanofi Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanofi and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Sanofi Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.94$1.14$1.02 Q2 20243$0.89$1.05$0.96 Q3 20243$1.30$1.64$1.42 Q4 20243$0.83$1.18$0.95 FY 202412$3.96$5.01$4.35 Q1 20251$1.09$1.09$1.09 Q2 20251$0.99$0.99$0.99 Q3 20251$1.38$1.38$1.38 Q4 20251$1.23$1.23$1.23 FY 20254$4.69$4.69$4.69 Q1 20261$1.17$1.17$1.17 Q2 20261$1.16$1.16$1.16 Q3 20261$1.35$1.35$1.35 Sanofi Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/6/2025(Estimated)------- 10/25/2024Q3 2024$0.22$1.57+$1.35$1.91$16.59B$13.44B 7/25/2024Q2 2024$0.88$0.93+$0.05$1.38$16.86B$10.75B 4/25/2024Q1 2024$0.96$0.96-$1.43$11.75B$11.36B2/1/2024Q4 2023$0.94$0.89 -$0.05$2.02$13.02B$11.76B10/27/2023Q3 2023$1.37$1.39+$0.02$1.67$13.61B$13.02B7/28/2023Q2 2023$0.88$0.95+$0.07$1.27$11.47B$10.85BOne coin could soar when Trump’s elected … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin.7/28/2023Q2 2023$0.88$0.95+$0.07$1.27$11.47B$10.85B 4/27/2023Q1 2023$1.10$1.16+$0.06$1.46$11.60B$10.97B4/27/2023Q1 2023$1.10$1.16+$0.06$1.46$11.60B$10.97B 2/3/2023Q4 2022$0.90$0.87 -$0.03$1.15$11.51B$10.95B2/3/2023Q4 2022$0.90$0.87 -$0.03$1.15$11.51B$10.95B Sanofi Earnings - Frequently Asked Questions When is Sanofi's earnings date? Sanofi has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates. Learn more on SNY's earnings history. Did Sanofi beat their earnings estimates last quarter? In the previous quarter, Sanofi (NASDAQ:SNY) reported $1.57 earnings per share (EPS) to beat the analysts' consensus estimate of $0.22 by $1.35. Learn more on analysts' earnings estimate vs. SNY's actual earnings. How can I listen to Sanofi's earnings conference call? The conference call for Sanofi's latest earnings report can be listened to online. Listen to Conference Call How can I read Sanofi's conference call transcript? The conference call transcript for Sanofi's latest earnings report can be read online. Read Transcript How much revenue does Sanofi generate each year? Sanofi (NASDAQ:SNY) has a recorded annual revenue of $46.61 billion. How much profit does Sanofi generate each year? Sanofi (NASDAQ:SNY) has a recorded net income of $5.84 billion. SNY has generated $1.96 earnings per share over the last four quarters. What is Sanofi's price-to-earnings ratio? Sanofi (NASDAQ:SNY) has a trailing price-to-earnings ratio of 24.78 and a forward price-to-earnings ratio of 11.32. The price/earnings-to-growth ratio is 1.22. What is Sanofi's EPS forecast for next year? Sanofi's earnings are expected to grow from $4.29 per share to $4.82 per share in the next year, which is a 12.35% increase. ` More Earnings Resources from MarketBeat Related Companies NVO Earnings NVS Earnings AZN Earnings GSK Earnings TAK Earnings BNTX Earnings TEVA Earnings BGNE Earnings MRNA Earnings VTRS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. This page (NASDAQ:SNY) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will con...DTI | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfe...Darwin | SponsoredHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buyi...Insiders Exposed | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But accor...WealthPress | Sponsored25X predicted for “Amazon Coin” – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
